2 Results for "

chemotherapy-induced emesis

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "chemotherapy-induced emesis" in MCE Product Catalog:

Cat. No.: HY-106982
CAS No.: 147116-64-1
Synonyms: CJ-11,974
Ezlopitant (CJ-11,974) is a selective, non-peptidic neurokinin-1 (NK-1)-receptor antagonist. Ezlopitant inhibits both acute and delayed emetic reactions induced by Cisplatin (HY-17394) in ferrets via acting on NK1 receptors in the central nervous system. Ezlopitant has the potential for pain, chemotherapy-induced emesis and irritable bowel syndrome research .
loading...
    loading...
Cat. No.: HY-183136
CAS No.: 102670-46-2
Synonyms: BMY 25801
Target:  

5-HT Receptor

Research Areas:  

Cancer

Batanopride (BMY 25801) is a selective 5-HT3 receptor antagonist. Batanopride inhibits chemotherapy-induced emesis, and prevents Cisplatin (HY-17394)-, Cyclophosphamide (HY-17420)-, Doxorubicin (HY-15142A)-, and total body irradiation-induced emesis .
loading...
    loading...